BIIB
Biogen to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Thursday, December 22, 2022 BiopharmaWatch Research 1 min read Key Takeaway: Biogen to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Price reaction · baseline $286.86 (2022-12-21 close) · hit after-hours · clean, no other BIIB news in the window
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis
Full Press Release Details
Biogen to Participate in the 41st Annual J.P. Morgan Healthcare Conference.